1-3 of 3
Smith Giri, MDMS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-Effectiveness of Once-Weekly Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Twice-Weekly Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma

Kishan Patel, BS, Terri L. Parker, MD, Mengyang Di, MD PhD, Noffar Bar, MD, Scott F. Huntington, MD MPH, Smith Giri, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–52.
https://doi.org/10.1182/blood-2020-141972
Published: 2020
Journal Articles

Multiple Myeloma (MM) in the Very Old: Disease Characteristics, Treatment Patterns and Outcomes in the Real World

Smith Giri, MDMS, Susan Bal, MDMBBS, Kelly N. Godby, MD, Grant R Williams, Luciano J. Costa, MD PhD, Smita Bhatia, MDMPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-143223
Published: 2020
Journal Articles

Role of Neutrophil Lymphocyte Ratio [NLR] As a Biomarker of Frailty and Predictor of Survival Among Older Adults with Multiple Myeloma (MM)

Smith Giri, MDMS, Susan Bal, MDMBBS, Kelly N. Godby, MD, Joshua Richman, MD PhD, Adam J Olszewski, MD, Grant R Williams, Luciano J. Costa, MD PhD, Smita Bhatia, MDMPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 6.
https://doi.org/10.1182/blood-2020-143290
Published: 2020